2016 Hematological Malignancies
HD15-PET trial Impact of response and PET status (TTP)
Time to progression 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0
NPV@12m: 94% (95% CI: 92% to 96%)
PR ≥ 2.5cm/PET-
CR/CRu (no PET)
PR ≥ 2.5cm/PET+
12
24
36
48
60
Months from randomization
Pts. at Risk
540 188 854
517 166 811
449 139 690
338 97 482
224 58 303
118 35 155
PET- PET+ CR/CRu
Made with FlippingBook